Comparison of different testosterone formulations discontinuation and dose spacing on hematocrit and testosterone levels in transgender individuals with erythrocytosis
Discontinuation of testosterone undecanoate for 3 months in trans men undergoing GAHT-T who had developed erythrocytosis reduces hemoglobin and hematocrit levels without a significant reduction in testosterone levels. Dose spacing in fortnightly testosterone cypionate users was not effective to reduce hematocrit and hemoglobin.
Authors
- Sílvio Antônio Franceschini (ORCID: https://orcid.org/0000-0002-5896-6524)
- Lúcia Alves da Silva Lara (ORCID: https://orcid.org/0000-0003-1073-238X)
- Luiz Gustavo Oliveira Brito (ORCID: https://orcid.org/0000-0002-7364-4718)
- Sérgio Henrique Pires Okano (ORCID: https://orcid.org/0000-0002-6046-2659)
Institutions
- Universidade de Ribeirão Preto (BR)
- Universidade Estadual de Campinas (UNICAMP) (BR)
- Pontifícia Universidade Católica de Campinas (BR)
Publication Details
- Journal
- Revista Brasileira Ginecologia e Obstetrícia
- Published
- 2025-01-01
- DOI
- https://doi.org/10.61622/rbgo/2025rbgo35
- Primary Topic
- LGBTQ Health, Identity, and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00